Get the Stockscreener App
14.45
0.14%
-0.02
Pre-market:
14.56
0.11
+0.76%
Certara Inc stock is traded at $14.45, with a volume of 2.03M.
It is down -0.14% in the last 24 hours and up +34.67% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$14.47
Open:
$14.59
24h Volume:
2.03M
Relative Volume:
1.16
Market Cap:
$2.24B
Revenue:
$363.55M
Net Income/Loss:
$-78.68M
P/E Ratio:
-28.90
EPS:
-0.5
Net Cash Flow:
$50.74M
1W Performance:
+4.11%
1M Performance:
+34.67%
6M Performance:
+28.67%
1Y Performance:
-10.58%
1-Day Range:
$14.09
$14.62
1-Week Range:
$13.35
$14.67
52-Week Range:
$8.635
$17.94
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
14.45 | 2.24B | 363.55M | -78.68M | 50.74M | -0.50 |
|
VEEV
Veeva Systems Inc
|
215.78 | 36.24B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
52.40 | 9.99B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
43.23 | 7.43B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
83.45 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.45 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Investing in Certara Inc (CERT): What You Must Know - knoxdaily.com
3 Momentum Stocks That Could Soar Post-Market Volatility - Investing.com
3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat
Where are the Opportunities in (CERT) - news.stocktradersdaily.com
Geode Capital Management LLC Sells 10,953 Shares of Certara, Inc. (NASDAQ:CERT) - Defense World
Computer Aided Drug Discovery Market Future Prospects 2030 | Certara, Chemical Computing Group - openPR.com
LPL Financial LLC Increases Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Will Certara (CERT) Beat Estimates Again in Its Next Earnings Report? - MSN
Certara, Inc. (NASDAQ:CERT) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Certara (NASDAQ:CERT) Stock Price Expected to Rise, KeyCorp Analyst Says - Defense World
Certara FY2025 EPS Estimate Increased by Leerink Partnrs - Defense World
Equities Analysts Set Expectations for Certara Q1 Earnings - Defense World
Leerink Partnrs Has Positive Outlook of Certara Q1 Earnings - Defense World
Certara Inc (CERT) Shares Gap Down to $13.69 on Apr 15 - GuruFocus
Certara expects Q1 sales above estimates - MSN
William Blair Analysts Lower Earnings Estimates for Certara - Defense World
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Certara, Inc.'s (NASDAQ:CERT) 32% Price Boost Is Out Of Tune With Revenues - simplywall.st
O Shaughnessy Asset Management LLC Has $138,000 Stake in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara (CERT) Exceeds Revenue Expectations with Strong Q1 Growt - GuruFocus
Certara (CERT) Explores Strategic Options for Regulatory Services Unit | CERT Stock News - GuruFocus
Certara (CERT) Reaffirms 2025 Financial Projections | CERT Stock News - GuruFocus
Why Certara Inc. (CERT) Soared Last Week? - MSN
Why Certara Inc. (CERT) Skyrocketed On Monday? - MSN
Certara (CERT) Secures One-Year Lock-Up Agreement with Arsenal C - GuruFocus
Certara's Stock Soars on Strong Revenue Guidance and AI-Driven Innovations - GuruFocus
Certara (CERT) Reports Strong Growth in Q1 2024 Performance | CE - GuruFocus
Certara launches Non-Animal Navigator for drug development By Investing.com - Investing.com South Africa
Certara announces Q1 revenue growth and $100 million buyback By Investing.com - Investing.com South Africa
Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report - Benzinga
Certara Launches Product for Biopharmaceutical Firms to Reduce Reliance on Animal Testing - marketscreener.com
Certara IncEntered Into Amendment To Previously Disclosed Letter Agreement Between Co And Arsenal Saturn Holdings Lp - MarketScreener
Certara Launches Non-Animal Navigator™ Solution to Help Drug Dev - GuruFocus
Certara announces Q1 revenue growth and $100 million buyback - Investing.com Australia
Certara (CERT) Introduces Non-Animal Navigator to Advance Precli - GuruFocus
Certara launches Non-Animal Navigator for drug development - Investing.com
Certara's Preliminary Q1 Revenue Increases; Reiterates 2025 Outlook; Authorizes $100 Million Share Buyback Plan - MarketScreener
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing - MarketScreener
Certara Launches Non- Animal Navigator?? Solution to Help Drug Developers Reduce Reliance on Animal Testing - marketscreener.com
Certara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase Authorization - The Manila Times
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio? - Benzinga
Robert W. Baird Raises Certara (NASDAQ:CERT) Price Target to $13.00 - Defense World
10 Firms Defy Market Slump, Record Double-Digit Gains Last Week - Insider Monkey
Certara Inc (CERT) Shares Up 18.36% on Apr 11 - GuruFocus
Certara (CERT) Receives Price Target Boost Following FDA Biosimu - GuruFocus
Barclays Has Lowered Expectations for Certara (NASDAQ:CERT) Stock Price - Defense World
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.76%
1.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):